2024 annual financial data
Lakewood-Amedex Biotherapeutics 2024 Operating income growth
Direct answer
Operating income growth was 53.38%.
Operating income was -4,026,820 USD and net income was -4,855,405 USD.
Operating cash flow was -5,723,322 USD.
Get free Lakewood-Amedex Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -4,026,820 USD
- Net income
- -4,855,405 USD
- Operating cash flow
- -5,723,322 USD